Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05019508 · ClinicalTrials.gov registry record
Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus
A clinical trial, sponsored by University of Virginia.
- Completed
- Registry status
- 114
- Enrollment target
NCT05019508: Completed study, sponsored by University of Virginia.
NCT05019508 is a clinical trial that has completed, run by University of Virginia. The registered enrollment target is 114 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05019508 has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 114 participants
- Enrollment target
Study Summary
This is a prospective cohort study to assess the predictive value of fetal cardiac parameters, the change in fetal cardiac parameters (CFP), HbA1c, and/or the change in HbA1c (ΔHbA1c) for gestational diabetes.
Primary Outcome
Area under the curve statistics will be used to assess values of CFP, ΔCFP, ΔHbA1c (independently and in conjunction) which maximize sensitivity, specificity, and PPV for GDM.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2021-08-13 |
| Est. Completion | 2023-04-10 |
What the finished NCT05019508 record still lists
NCT05019508 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05019508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05019508 about?
NCT05019508 is a clinical study titled "Fetal Cardiac Function Parameters and HbA1c As Screening for Gestational Diabetes Mellitus". This is a prospective cohort study to assess the predictive value of fetal cardiac parameters, the change in fetal cardiac parameters (CFP), HbA1c, and/or the change in HbA1c (ΔHbA1c) for gestational diabetes.
What is the current status of trial NCT05019508?
This trial is currently completed. The enrollment target is 114 participants. The study started on 2021-08-13. Estimated completion is 2023-04-10.
Who is sponsoring clinical trial NCT05019508?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI